cro.directory
← Compare landing

NorthernBio vs PharmaLegacy Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/northernbiolab/pharmalegacy

CategoryNorthernBioPharmaLegacy Laboratories
Listed sitecrocro
SummaryMichigan-based preclinical CRO specializing in GLP-compliant in vivo safety assessment, targeted drug delivery, molecular biology, and ligand binding bioanalysis across neuroscience, ophthalmology, cardiovascular, metabolic, and rare disease indications.Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.
Services
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Bioanalysis
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Safety Pharmacology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Neurology
  • Ophthalmology
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Oncology
  • Immunology
  • Rare Disease
Locations
  • Muskegon, Muskegon, Michigan, United States
  • Norton Shores, Norton Shores, Michigan, United States
  • Portage, Portage, Michigan, United States
  • Headquarters
Certifications
  • FDA · Identifier: 21 CFR Part 58
  • FDA · Identifier: 21 CFR Part 11
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.